title: Marked chromogranin A elevation in a patient with bilateral adrenal incidentalomas, and its rapid normalization after discontinuation of proton pump inhibitor therapy.
authors.forename: Peter
authors.initials: P
authors.lastname: Igaz
authors.forename: Katalin
authors.initials: K
authors.lastname: Müllner
authors.forename: Beáta
authors.initials: B
authors.lastname: Hargitai
authors.forename: Ivan
authors.initials: I
authors.lastname: Igaz
authors.forename: Zsófia
authors.initials: Z
authors.lastname: Tömböl
authors.forename: Károly
authors.initials: K
authors.lastname: Rácz
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Tulassay
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects*; D000310:Adrenal Gland Neoplasms / Q000097:blood / Q000000981:diagnostic imaging*; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D053379:Chromogranin A / Q000097:blood*; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D064747:Lansoprazole; D010673:Pheochromocytoma / Q000097:blood / Q000000981:diagnostic imaging*; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D014463:Ultrasonography
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D014408:Biomarkers, Tumor; D053379:Chromogranin A; D054328:Proton Pump Inhibitors; D064747:Lansoprazole